Tennis Elbow Release

Indication. Surgery for lateral epicondylitis (tennis elbow) is reserved for the small minority whose symptoms have persisted despite a genuine trial of non-operative care. The diagnosis is clinical: lateral elbow pain of insidious onset, worse with gripping and lifting, with point tenderness maximal 1 cm distal and anterior to the lateral epicondyle (over the ECRB origin). Three provocation tests support it: - Cozen test — resisted wrist extension with the elbow extended and forearm pronated reproduces pain.

• Mills test — passive wrist flexion with the elbow extended and forearm pronated reproduces pain.
• Maudsley test — resisted middle-finger extension reproduces pain when ECRB is involved. Investigations are adjuncts, not requirements. X-ray is usually normal but may show calcification at the lateral epicondyle. MRI shows signal change at the ECRB origin on the anterior facet, with possible partial- or full-thickness tears — useful pre-operatively for planning and to exclude other pathology. Ultrasound shows a hypoechoic area, tendon thickening and neovascularisation at the origin. Exclude concurrent pathology before attributing pain to tennis elbow. Several conditions mimic or coexist with lateral epicondylitis and change management: - Radial tunnel syndrome (PIN compression) — point of maximal tenderness 4-5 cm distal to the lateral epicondyle over the radial head and neck, pain worse with resisted supination; distinct from tennis elbow.
• Medial epicondylitis — coexists in up to 10% of cases.
• Cervical radiculopathy (C6 dermatomal overlap).
• Osteochondritis dissecans of the capitellum — particularly in younger patients or racquet-sport athletes.
• Posterior interosseous nerve entrapment — may mimic or coexist with lateral epicondylitis. Surgery is a last resort. Most patients never need it. The conservative ladder should be exhausted first: | Step | Treatment | Evidence | |------|-----------|----------| | 1 | Activity modification, NSAIDs, physiotherapy (stretching, eccentric exercises) | First-line; 80-85% resolve without surgery | | 2 | Counterforce forearm orthosis (brace) | Reduces ECRB load; symptom relief in 60-70% | | 3 | Corticosteroid injection | Large short-term (4-week) pain reduction but inferior at 26 and 52 weeks — short-term gain, long-term harm (Coombes et al, Lancet 2010) | | 4 | PRP injection (leukocyte-rich) | No difference versus needling control at 12 weeks, but significantly better at 24 weeks (84% versus 68% success) — Mishra et al, AJSM 2014 | | 5 | Extracorporeal shockwave therapy (ESWT) | Reserved for chronic refractory cases; evidence inconsistent across trials | Surgical indications. Offer surgery when there is confirmed lateral epicondylitis (Nirschl tendinosis stage 2-3) with persistent functional impairment, after: - Failed conservative treatment for a minimum of 6-12 months.
• Failure of at least 2 non-operative modalities.
• A confirmed diagnosis (clinical, plus or minus MRI or ultrasound). Relative contraindications: active infection, anticoagulation, systemic inflammatory arthropathy (treat the underlying disease first), and bilateral medial and lateral epicondylitis (which may indicate a systemic cause). The one decision — which technique. Open, percutaneous and arthroscopic releases all begin from the same principle: identify the pathological ECRB and excise it. The choice rests on surgeon experience and whether the joint needs assessment:

Consent specifically for lateral-sided numbness or a painful neuroma, scar tenderness, residual or recurrent pain (10-20%), infection, stiffness, and the rare but serious risks of posterolateral rotatory instability and posterior interosseous nerve injury. Setup. Supine with the arm on an arm board, upper-arm tourniquet, regional or general anaesthesia. Flex the elbow to 90 degrees and pronate the forearm so the lateral epicondyle faces upward.

The goal is to expose the ECRB origin through a short lateral incision, excise the grey pathological angiofibroblastic tissue completely, decorticate the anterior facet of the lateral epicondyle to promote healing, and repair the extensor aponeurosis — all while protecting the lateral collateral ligament complex posteriorly, the posterior interosseous nerve distally, and leaving the healthy ECRL entirely untouched. The open modified Nirschl technique is laid out step by step below; the arthroscopic alternative follows.

View larger

View larger

Arthroscopic release is the alternative when concurrent intra-articular assessment is wanted. Position supine (arm across the chest) or in lateral decubitus, with a tourniquet and the elbow flexed to 90 degrees. Establish three portals: a proximal medial portal (2 cm proximal and 1 cm anterior to the medial epicondyle) for inflow, an anterolateral viewing portal (1 cm distal and 1 cm anterior to the lateral epicondyle), and a proximal lateral working portal (1 cm proximal to the lateral epicondyle). Distend the joint with 20-30 mL of saline through the posterior soft spot, then survey the capitellum (OCD), synovium, coronoid and anterior capsule. The ECRB undersurface appears as grey, hypertrophic tissue at the anterolateral capsule adjacent to the radiocapitellar joint; debride it with a 4.0 mm shaver until normal extensor muscle fibres are visible.

View larger

Immediate post-operative period (0-2 weeks). Immobilise in a short arm volar splint with the wrist in 20-30 degrees of extension for 7-10 days to protect the repair. Check the wound at 7-10 days and remove sutures or clips at 12-14 days. Simple analgesia (paracetamol, an NSAID if not contraindicated); avoid opioids beyond 48 hours. Elevate for 48 hours and ice for 20 minutes every 2-3 hours to reduce swelling. Physiotherapy programme (2-12 weeks). - Weeks 2-4 — gentle active range of motion: wrist flexion and extension, forearm pronation and supination, elbow flexion and extension. No resistance.

• Weeks 4-6 — begin isometric wrist and forearm strengthening, scar massage, and progress to light functional tasks.
• Weeks 6-12 — progressive-resistance wrist-extensor exercises (concentric and eccentric) and grip strengthening. Return to light work is permitted at 6 weeks. Return to activity. | Activity | Timeframe | |----------|-----------| | Light activities of daily living | 2-4 weeks | | Light manual work / office work | 4-6 weeks | | Moderate physical work | 8-12 weeks | | Racquet sports / heavy manual labour | 3-6 months | | Competitive sport (full intensity) | 4-6 months | Prognosis. Roughly 80-90% of patients achieve good-to-excellent outcomes (Nirschl and Pettrone 1979 reported 97.7% improved; the Kholinne 2024 meta-analysis pooled success at about 82.7% open, 91.0% percutaneous and 91.9% arthroscopic). Around 10-20% have residual symptoms or recurrence at 1-2 years. Return to work is faster after less-invasive techniques — about 3 weeks earlier with percutaneous than open in the Dunkow 2004 RCT, and around 2.2 weeks in Baker's arthroscopic series. Predictors of a poorer outcome include workers' compensation claims, bilateral disease, symptoms lasting more than 12 months, and concurrent shoulder or cervical pathology. Complications.

The lesion is degeneration, not inflammation. Nirschl and Pettrone (1979) established that the pathological process in tennis elbow is angiofibroblastic hyperplasia of the ECRB origin — proliferation of disorganised fibroblasts, immature type III collagen and vascular ingrowth, with an absence of true inflammatory cells. The affected tissue is grey, glistening, avascular and friable, quite unlike healthy white, fibrous, organised tendon. This is why the term 'tendinopathy' is preferred to 'tendinitis'. ECRB, not ECRL. ECRB arises from the anterior facet of the lateral epicondyle (deep to ECRL), inserts on the base of the third metacarpal, extends the wrist, and is innervated by the posterior interosseous nerve. ECRL arises more proximally from the lateral supracondylar ridge, is innervated by the radial nerve proper, and is superficial and uninvolved — it is never released. Nirschl pathological staging of tendinosis. This is a conceptual staging of progressive angiofibroblastic tendinosis attributed to Nirschl; the original 1979 Nirschl and Pettrone paper described the angiofibroblastic ECRB lesion itself.

Key evidence. The high-level evidence does not show one surgical technique to be clearly superior. The Kholinne 2024 meta-analysis (43 studies, 1,941 elbows) pooled success at 91.9% arthroscopic, 91.0% percutaneous and 82.7% open, but the evidence base is predominantly low level. The Dunkow RCT (2004) compared open with percutaneous tenotomy and favoured percutaneous for earlier return to work and greater DASH improvement. For non-operative care, the Coombes Lancet systematic review (2010) showed corticosteroid injection gives a large short-term benefit but worse outcomes at 26 and 52 weeks than no intervention, while the Mishra RCT (2014, 230 patients) found leukocyte-rich PRP no better than needling at 12 weeks but significantly better at 24 weeks (84% versus 68% success).